In August, faced with the prospect of injecting a groundbreaking weight-loss drug, I pondered the unfamiliar territory of not feeling hungry. Having shed 40 pounds since then, I’ve recently administered my last affordable dose, sparking curiosity about returning to a normal appetite.

Hunger had long shaped my existence, especially as someone who battled weight issues. A decade ago, I triumphantly lost 100 pounds through a strict diet and exercise regimen. However, I succumbed to food cravings, reaching 233 pounds by my 44th birthday last year. The struggle persisted, and my BMI officially labeled me as “obese” for the first time in 14 years.

Traditional dieting proved futile, leading me to explore a new frontier – weekly injections of GLP-1 drugs like Mounjaro. This class of medications, initially developed for diabetes, has become a game-changer in the weight loss realm. Despite most insurers not covering these drugs for weight loss, I opted for Mounjaro, anticipating its efficacy from clinical trials showing significant body weight reduction.

Facing the financial burden, I embarked on a three-month drug regimen, defying my doctor’s recommendation to stretch it over five months. The initial injections brought relief from relentless food cravings, offering a newfound sense of ease in weight loss.

Around week 10, with 21 pounds shed, compliments poured in, yet they carried an unexpected discomfort. I questioned others’ perceptions before my weight loss and struggled to navigate the conversations. Research indicated that conventional diets rarely sustain long-term results, amplifying my frustration with the diet industry.

As the treatment continued, I grappled with the drug’s impact on my enjoyment of food and contemplated the inevitable withdrawal. Despite concerns, slipping into an old shirt marked a symbolic victory, signaling the changes in my physique. The holidays saw me effortlessly maintaining weight loss during a period notorious for diet setbacks.

Completing my final injection, I marveled at the physical and mental transformations. From a chiseled face to slipping wedding rings, the changes were tangible. The mental shift from acceptance to belief in lasting weight loss felt profound. Reflecting on past weight-loss attempts, I acknowledged the importance of mindset in sustaining efforts.

Drawing parallels with Oliver Sacks’ “Awakenings,” I recognized the temporary success of this medication, prompting contemplation about its long-term viability. The next frontier involves exploring a balance between these drugs and established diet and exercise programs. Despite uncertain outcomes, hope prevails as millions, including myself, navigate this evolving landscape.